Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Continuous Glucose Monitoring in Pediatrics: The Gap between Potential Benefits and the Reality of Utility.

Taddeo RL, Moser JT, Minnock PP.

Pediatr Endocrinol Rev. 2017 Jun;14(Suppl 2):435-440. doi: 10.17458/per.vol14.2017.tmm.glucosemonitoring.

PMID:
28647947
2.

Perceptions of the Cause, Impact and Management of Persistent Fatigue in Patients with Rheumatoid Arthritis Following Tumour Necrosing Factor Inhibition Therapy.

Minnock P, Ringnér A, Bresnihan B, Veale D, FitzGerald O, McKee G.

Musculoskeletal Care. 2017 Mar;15(1):23-35. doi: 10.1002/msc.1136. Epub 2016 Feb 12.

PMID:
26871999
3.

Factors that influence fatigue status in patients with severe rheumatoid arthritis (RA) and good disease outcome following 6 months of TNF inhibitor therapy: a comparative analysis.

Minnock P, Veale DJ, Bresnihan B, FitzGerald O, McKee G.

Clin Rheumatol. 2015 Nov;34(11):1857-65. doi: 10.1007/s10067-015-3088-6. Epub 2015 Oct 9.

4.

How much is fatigue explained by standard clinical characteristics of disease activity in patients with inflammatory arthritis? A longitudinal study.

Minnock P, McKee G, Bresnihan B, FitzGerald O, Veale DJ.

Arthritis Care Res (Hoboken). 2014 Nov;66(11):1597-603. doi: 10.1002/acr.22387.

5.

Patient involvement in outcome measures for psoriatic arthritis.

Tillett W, Adebajo A, Brooke M, Campbell W, Coates LC, FitzGerald O, Gossec L, Helliwell P, Hewlett S, James J, Minnock P, Reast A, O'Sullivan D, de Wit M, McHugh N.

Curr Rheumatol Rep. 2014 May;16(5):418. doi: 10.1007/s11926-014-0418-7. Review.

PMID:
24623563
6.

Comparison of remission criteria in a tumour necrosis factor inhibitor treated rheumatoid arthritis longitudinal cohort: patient global health is a confounder.

Balogh E, Madruga Dias J, Orr C, Mullan R, Harty L, FitzGerald O, Gallagher P, Molloy M, O'Flynn E, Kelly A, Minnock P, O'Neill M, Moore L, Murray M, Fearon U, Veale DJ.

Arthritis Res Ther. 2013 Dec 24;15(6):R221. doi: 10.1186/ar4421.

7.

Patient perspective workshop: moving towards OMERACT guidelines for choosing or developing instruments to measure patient-reported outcomes.

Kirwan JR, Fries JF, Hewlett SE, Osborne RH, Newman S, Ciciriello S, van de Laar MA, Dures E, Minnock P, Heiberg T, Sanderson TC, Flurey CA, Leong AL, Montie P, Richards P.

J Rheumatol. 2011 Aug;38(8):1711-5. doi: 10.3899/jrheum.110391.

PMID:
21807790
8.

Use of continuous glucose monitoring systems in children with type 1 diabetes.

Minnock PP, Howe CJ.

Crit Care Nurs Clin North Am. 2011 Jun;23(2):273-90. doi: 10.1016/j.ccell.2011.04.004. Review.

PMID:
21624690
9.

Smokers and non smokers with rheumatoid arthritis have similar clinical status: data from the multinational QUEST-RA database.

Naranjo A, Toloza S, Guimaraes da Silveira I, Lazovskis J, Hetland ML, Hamoud H, Peets T, Mäkinen H, Gossec L, Herborn G, Skopouli FN, Rojkovich B, Aggarwal A, Minnock P, Cazzato M, Yamanaka H, Oyoo O, Rexhepi S, Andersone D, Baranauskaite A, Hajjaj-Hassouni N, Jacobs JW, Haugeberg G, Sierakowski S, Ionescu R, Karateew D, Dimic A, Henrohn D, Gogus F, Badsha H, Choy E, Bergman M, Sokka T.

Clin Exp Rheumatol. 2010 Nov-Dec;28(6):820-7. Epub 2011 Jan 3.

PMID:
21205460
10.

New technologies in pediatric diabetes care.

Carchidi C, Holland C, Minnock P, Boyle D.

MCN Am J Matern Child Nurs. 2011 Jan-Feb;36(1):32-9; quiz 40-1. Review.

PMID:
21204305
11.

Fatigue is an independent outcome measure and is sensitive to change in patients with psoriatic arthritis.

Minnock P, Kirwan J, Veale D, Fitzgerald O, Bresnihan B.

Clin Exp Rheumatol. 2010 May-Jun;28(3):401-4. Epub 2010 Jun 23.

PMID:
20525443
12.

Fatigue is a reliable, sensitive and unique outcome measure in rheumatoid arthritis.

Minnock P, Kirwan J, Bresnihan B.

Rheumatology (Oxford). 2009 Dec;48(12):1533-6. doi: 10.1093/rheumatology/kep287. Epub 2009 Sep 22.

PMID:
19773406
13.

Progress on incorporating the patient perspective in outcome assessment in rheumatology and the emergence of life impact measures at OMERACT 9.

Kirwan JR, Newman S, Tugwell PS, Wells GA, Hewlett S, Idzera L, Laslo B, March LM, Minnock P, Montie P, Nicklin J, Rader T, Richards P, Sanderson TC, Suarez-Almazor M, Tanjong-Ghogomu E, Ueffing E, Welch V.

J Rheumatol. 2009 Sep;36(9):2071-6. doi: 10.3899/jrheum.090360.

PMID:
19738216
14.

Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database.

Sokka T, Kautiainen H, Pincus T, Toloza S, da Rocha Castelar Pinheiro G, Lazovskis J, Hetland ML, Peets T, Immonen K, Maillefert JF, Drosos AA, Alten R, Pohl C, Rojkovich B, Bresnihan B, Minnock P, Cazzato M, Bombardieri S, Rexhepi S, Rexhepi M, Andersone D, Stropuviene S, Huisman M, Sierakowski S, Karateev D, Skakic V, Naranjo A, Baecklund E, Henrohn D, Gogus F, Badsha H, Mofti A, Taylor P, McClinton C, Yazici Y.

Ann Rheum Dis. 2009 Nov;68(11):1666-72. doi: 10.1136/ard.2009.109983. Epub 2009 Jul 30.

15.

Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study.

Sokka T, Toloza S, Cutolo M, Kautiainen H, Makinen H, Gogus F, Skakic V, Badsha H, Peets T, Baranauskaite A, Géher P, Ujfalussy I, Skopouli FN, Mavrommati M, Alten R, Pohl C, Sibilia J, Stancati A, Salaffi F, Romanowski W, Zarowny-Wierzbinska D, Henrohn D, Bresnihan B, Minnock P, Knudsen LS, Jacobs JW, Calvo-Alen J, Lazovskis J, Pinheiro Gda R, Karateev D, Andersone D, Rexhepi S, Yazici Y, Pincus T; QUEST-RA Group.

Arthritis Res Ther. 2009;11(1):R7. doi: 10.1186/ar2591. Epub 2009 Jan 14.

16.

Fatigue is related to poor pain outcomes in women with established rheumatoid arthritis.

Minnock P, Bresnihan B.

Clin Exp Rheumatol. 2008 Jul-Aug;26(4):707-8. No abstract available.

PMID:
18799112
17.

Consistency in assessing the Disease Activity Score-28 in routine clinical practice.

Walsh CA, Mullan RH, Minnock PB, Slattery C, FitzGerald O, Bresnihan B.

Ann Rheum Dis. 2008 Jan;67(1):135-6. No abstract available.

PMID:
18077544
18.

Quality of life and economic impact of switching from established infliximab therapy to adalimumab in patients with rheumatoid arthritis.

Walsh CA, Minnock P, Slattery C, Kennedy N, Pang F, Veale DJ, Bresnihan B, FitzGerald O.

Rheumatology (Oxford). 2007 Jul;46(7):1148-52. Epub 2007 May 3.

PMID:
17478471
19.

Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis.

Kirwan JR, Minnock P, Adebajo A, Bresnihan B, Choy E, de Wit M, Hazes M, Richards P, Saag K, Suarez-Almazor M, Wells G, Hewlett S.

J Rheumatol. 2007 May;34(5):1174-7.

PMID:
17477482
20.

Incorporating the patient perspective into outcome assessment in rheumatoid arthritis--progress at OMERACT 7.

Kirwan JR, Hewlett SE, Heiberg T, Hughes RA, Carr M, Hehir M, Kvien TK, Minnock P, Newman SP, Quest EM, Taal E, Wale J.

J Rheumatol. 2005 Nov;32(11):2250-6.

PMID:
16265712

Supplemental Content

Loading ...
Support Center